Clinical Study | Office of Clinical Research

A Feasibility Trial Of The Modified Atkins Diet And Bevacizumab For Recurrent Glioblastoma

Posted Date: May 15, 2019

Investigator: Rekha Chaudhary
Type of Study: Drug

The purpose of this study is to research if patients can stay on the Modified Atkins Diet (MAD) when it is added to the standard bevacizumab treatment.

Criteria:

To Be Eligible To Participate In This Study, Patients Must Have Glioblastoma (A Brain Tumor) That Ha

Keywords:

Brain, Cancer, Case 10314, Feasibility, Glioblastoma

For More Information:

Uc Cancer Center
(513) 584-7698
cancer@uchealth.com

Name*
First Last
Gender*
- Male
- Female
Age*
Phone*
Email*
How did you hear about us?*
Future Communication*
- By submitting this form, I am agreeing to receive future communication about participating in an upcoming research study.
CAPTCHA
This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.
List